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TO THE EDITOR
Solitary or multiple cutaneous leiomyo-
mas are benign tumors derived from
vascular, areolar, dartos, or pilar
smooth muscle fibers (Holst et al.,
2002), which can be part of a syndrome
when associated with MCUL (Garman
et al., 2003). Furthermore, 15–62% of
MCUL patients may develop a papillary
renal type II or renal duct cancer
HLRCC configuring a more complex
entity (MCUL/HLRCC, OMIM 150800)
(Toro, 2003). This syndrome is due to
heterozygous mutations in the FH gene
(Kiuru et al., 2001; Tomlinson et al.,
2002), which acts as a tumor-suppres-
sor gene to protect cells from hypoxic
stress (Pollard, 2005). Homozygous
mutations cause a complete FHD syn-
drome (FHD; OMIM 606812), which is
lethal in childhood (Bourgeron et al.,
1994). FH enzymatic activity is absent
in FHD, reduced by nearly 50% in
MCUL/HLRCC, and very low or absent
in tumors from MCUL patients (Tom-
linson et al., 2002), suggesting loss of
heterozygosity. Besides FH, a number
of different Krebs cycle genes have also
been found to be mutated in neo-
plasms, such as SDH in paraganglioma
and pheochromocytoma (Baysal, 2000;
Niemann and Muller, 2000); or in neo
or hyper vascular conditions such as in
VHL syndrome (Kim and Kaelin, 2004).
We performed a study in an Italian
family (Figure 1a) (consanguinity was
not reported). Informed consents were
obtained and approved by the Institu-
tional Review Boards according to
the Declaration of Helsinki Principles.
Patients I-2, II-2, and III-2 exhibited
cutaneous leiomyomas, and in addi-
tion, patients I-2 and II-2 had under-
gone a hysterectomy for uterine
fibroids. Patient II-2, a 62-year-old
woman, presented multiple painful
skin-colored papules and nodules on
the upper limbs and trunk (Figure 1b).
Patient III-2, a 35-year-old man, was
affected by multiple cutaneous lesions
on the abdomen; 3 months before
diagnosis, he had reported a sudden
loss of consciousness without subse-
quent neurological or ophthalmic defi-
cit. Immunohistochemical staining
of skin biopsies from patients II-2 and
III-2, using muscle-specific antibodies,
were positive (data not shown). To
investigate the loss of consciousness in
patient III-2 and the possible presence
of renal neoplasia, we performed an
MRI study, which revealed multiple,
well-defined lesions in both cerebral
and cerebellar hemispheres (Figure 1c
and d). The heterogeneous signal in-
tensity or ‘‘popcorn-like’’ appearance is
the result of a hemorrhage in different
stages of evolution. The hypointensity
on gradient-echo images reflects micro-
scopic deposits of hemosiderin and/or
calcification, a typical finding of cere-
bral cavernomas. CT scan and MRI
analysis of the mother (II-2) excluded
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Figure 1. Pedigree, clinical presentation, and MRI study. (a) Pedigree of the family showing affected
members spanning four generations. Only patient I-2 was not studied by MRI because of her old age.
(b) Picture of patient II-2 showing the presence of cutaneous leiomyomas that presented as firm brown
nodules localized on the upper limbs. (c) Axial MR T2-weighted image from patient III-2 shows an
intra-axial right temporal mass (arrow) with a complete rim of hypointensity (hemosiderin) and a
reticulated core, which is heterogeneously hyper-intense (‘‘popcorn-like’’) consistent with cerebral
cavernomas. (d) Axial gradient-echo image at the level of the centrum semiovale shows at least two
cavernomas in the left hemisphere (arrows); similar features are visible in patient II-2.
Abbreviations: CCM, cerebral cavernoma malformation; FH, fumarate hydratase; FHD, fumarate
hydratase deficiency; HLRCC, hereditary leiomyomatosis and renal cell cancer; HIF, hypoxia-inducible
factors; MCUL, multiple cutaneous and uterine leiomyomas; MRI, magnetic resonance imaging;
SDH, succinate dehydrogenase; VHL, Von Hippel Lindau
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renal neoplasia, but showed the same
cerebral pattern (data not shown).
Possible co-segregation of familial
CCM syndrome (OMIM 116860) was
excluded since molecular analysis of
CCM genes was negative (data not
shown). Analysis of the FH gene de-
monstrated, in one of the alleles, the
presence of two ‘‘in frame’’ copies of
exon 7 (Figure 2a), which, from the
analysis of exon 7 flanking sequences,
arises from an alteration of the FH gene
at genomic level (Figure 2b). The
duplication involves a portion of the
gene flanking introns 6 and 7, resulting
in an additional exon 7 (exon 70), and in
a new hybrid intron (Figure 2c), formed
by part of intron 7 and part of intron 6
(intron 70). As this duplication is flanked
by an AluSq SINE-repeated sequence
(Figure 2c), it is probably due to an
ectopic crossing over involving this
repeated sequence.
The analysis of genomic DNA of all
family members revealed the presence
of the duplication (Figure 2b) in both
the proband and his affected mother,
whereas it was absent in the unaffected
family members. Proband IV-1 was a
4-year-old boy, who, although currently
asymptomatic, was also carrying the
mutation (Figure 2b) with a high risk of
developing the disease later in his life.
Structural studies suggested that the
duplication of exon 7 results in the
addition of a helical domain protruding
from the active site (Figure 2d and e),
which presumably interferes with the
correct tetramerization process and/or
opening of the active site to aqueous
solvent. We also assayed FH activity in
the peripheral lymphocytes (Hatch,
1978); this showed that affected family
members (II-2, III-2, IV-1) had an
enzymatic activity that was less than
half that of non-affected family mem-
bers (1874, 2576, 3276 nU/mg/min,
respectively, compared with II-1,
7674; III-1, 54713), and healthy con-
trols (C-1, 8279; C-2, 81725; C-3,
90711), thus confirming the genetic
analysis.
The mechanism by which FH muta-
tions promote tumorigenesis has yet to
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Figure 2. Molecular, genetic, and structural analysis of FH. (a), RT-PCR of the whole FH transcript (primers: þ 50-AATTCTACCCAAGCTCCCTC-30;
50-AAATTGCTCTGCTAGAGATGC-30), showing the extra band due to the mutated allele, approximately700 bp larger than the wild type. The extra band (asterisks) is
present in all affected members. (b) Analysis of genomic DNA (primers: þ 50-AGGGTTTGGCAAATGTAGATT-30; 50-TCAGTATGAGTGTGAGGCAATTAG-30),
showing the presence of the mutated allele (asterisks) demonstrating that the duplication detected on the mRNA is due to a duplication present in the
genomic DNA. (c) Schematic representation of the mutation. The duplication of a region of 925 bp, containing exon 7 and part of the flanking introns, 6 and 7,
generates an additional exon (exon 70) and a functional hybrid intron (intron 70) (oblique stripes). Model structure of wild-type fumarase enzyme, based on
yeast template 1YFM.pdb (d) compared to the mutant enzyme (e). The models obtained were processed using DeepView/Swiss PdbViewer v 3.7 from
GlaxoSmithKline. The active site (green) is formed by the tetrameric interaction of four identical molecules (not shown). The duplication of exon 7 in the
mutant form creates an extra helical domain protruding from the active site. This domain also contains a duplication of a portion of the active site (white arrows),
probably causing the loss of activity of the mutant enzyme.
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be fully clarified. The increased cyto-
plasmic concentrations of fumarate or
succinate substrates, due to low or
absent FH/SDH activity, inhibit the
degradation of HIF. Persistence of HIF
induces activation of sustained hypoxic
response signals, which are considered
to be involved in hypervascularization
or neoplastic growth (Pollard, 2005).
However, some major questions still
remain unanswered. Why, for example,
do mutations in FH, SDH or VHL genes,
that are components of the same path-
way of hypoxia detection, cause differ-
ent tumors? Moreover, as a unique
mutation should lead to a unique
phenotype, could the specific duplica-
tion of exon 7, which we detected in
this family, be in some way related to
cerebral cavernomas? To our knowl-
edge this is the first time that cerebral
angiomatous lesions are described in
MCUL patients. We believe that this
finding adds new insight into the
genetic background of this syndrome,
suggesting that a reassessment of the
overall clinical spectrum of MCUL
might be required.
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TO THE EDITOR
Dorfman–Chanarin syndrome (DCS:
OMIM No. 275630), also referred to
as neutral lipid storage disease, is a
recessive disorder characterized by
ichthyosiform erythroderma variably
associated with liver steatosis, muscle
weakness, neurosensory deafness, and
subcapsular cataracts. DCS is asso-
ciated with accumulation of lipid
vacuoles in many tissues (Chanarin
et al., 1975) and related to a blockage
in the catabolism of triacylglycerol (Igal
and Coleman, 1996). We previously
demonstrated that mutations in a new
gene CGI-58 underlie DCS (Lefe`vre
et al., 2001). In this study, we report
a novel mutation of CGI-58 (S115G)
in a patient with DCS of Turkish
origin.
An 18-month-old Turkish girl was
referred to a department of haemato-
logy for workup of splenomegaly. At
birth, she presented with fine scales and
erythema over her entire body, consis-
tent with congenital non-bullous
ichthyosiform erythroderma. At age 18
months, multiple laboratory abnormal-
ities were present: elevated liver
enzymes related to hepatic steatosis
Abbreviations: ATGL, adipose triglyceride lipase; DCS, Dorfman–Chanarin syndrome; OMIM, Online
Mendelian Inheritence in Man; RT-PCR, reverse transcription-PCR
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